ARCT

ARCT Operating Expenses

$122.95MTTM · USD

Period ending:

ARCT FY Operating ExpensesUSD
ARCT FY Operating Expenses2011-12-31: $3.91M2012-12-31: $1.50M2013-12-31: $10.29M2014-12-31: $33.08M2015-12-31: $19.70M2016-12-31: $25.17M2017-12-31: $23.49M2018-12-31: $37.56M2019-12-31: $46.30M2020-12-31: $25.12M2021-12-31: $215.21M2022-12-31: $193.58M2023-12-31: $235.95M2024-12-31: $234.06M2025-12-31: $139.15M$235.95M$0.00
2011-12-312025-12-31

Source: Financial Modeling Prep (FMP). Annual fiscal periods; reported in USD. Dates are period ends; a fiscal year may differ from a calendar year.

ARCT operating expenses history

Expenses from normal business operations (SG&A, R&D, etc.). The available annual fiscal periods series contains 15 observations from Dec 31, 2011 to Dec 31, 2025.

Arcturus Therapeutics Holdings Inc Operating Expenses — Annual fiscal periods (USD)
Period endingOperating Expenses (USD)
139,151,000
234,058,000
235,953,000
193,578,000
215,211,000
25,117,000
46,302,000
37,564,000
23,490,000
25,167,000
19,698,000
33,078,000
10,290,000
1,501,000
3,906,000

Compare operating expenses

All ARCT financial metrics · ARCT stock overview · How to interpret financial metrics

Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.